Torres Vilanova, Cèlia
(10-09-2023)
Abstract
Motivation: Ivermectin inhibits SARS-CoV-2 replication in vitro at concentrations 35 times higher than approved clinical dosages for humans. This finding prompted numerous randomized clinical trials to assess its ...